Ligand-based drug design studies using predictive pharmacophore model generation on 4H-1,2,4-triazoles as AT 1 receptor antagonists

Medicinal Chemistry Research

Volumn 21, Issue 9, 2012, Pages 2307-2315

  Paliwal, Sarvesh ^a   Pal, Mahima ^a   Yadav, Divya ^a   Singh, Supriya ^a   Yadav, Rakesh ^a  

^a BANASTHALI UNIVERSITY   (India)

Author keywords

4H 1,2,4 triazoles; Angiotensin II receptor antagonists; Pharmacophore mapping

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AROMATIC COMPOUND; LIGAND;

ALGORITHM; ARTICLE; DRUG CONFORMATION; DRUG DESIGN; DRUG POTENCY; HYDROPHOBICITY; IC 50; PHARMACOPHORE; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

EID: 84866375800     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9756-4     Document Type: Article

References (21)

1. Ashton WT, Cantone CL, Chang LL, Hutchine SM, Strelitz RA, MacCoea M, Chang RL, Lotti VJ, Faust KA, Chen TB, Bunting P, Schorn TW, Kivlighn SD, Sieglt PKS (1993) Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and SH-imidazo [1,2-b][1,2,4]triazoles. J Med Chem 36:591-609 (Pubitemid 23097424)
2. Bondensgaard K, Ankersen M, Thogersen H, Hansen BS, Wulff BS, Bywater RP (2004) Recognition of privileged structures by G-protein coupled receptors. J Med Chem 47:888-899 (Pubitemid 38176791)
3. Brooks BR, Bruccoleri RF, Olafson BD, States DJ, Swaminathan S, Karplus M (1983) CHARMM: a program for macromolecular energy minimization and dynamics. J Comput Chem 4:187-217
4. Clark DE, Westhead DR, Sykes RA, Murray CW (1996) Active sitedirected 3D database searching: pharmacophore extraction and validation of hits. J Comput Aided Mol Des 10:397-416 (Pubitemid 126712437)
5. Doweyko AM (1994) Three-dimensional pharmacophores from binding data. J Med Chem 37:1769-1778 (Pubitemid 24219767)
6. Ellis ML, Patterson JH (1996) A new class of antihypertensive therapy: angiotensin II receptor antagonists. Pharmacotherapy 16:849-860 (Pubitemid 26322187)
7. Goodfriend TL, Elliot ME, Catt KJ (1996) Drug therapy: angiotensin receptors and antagonists. N Engl J Med 334:1649-1655
8. Hecker EV, Duraswami C, Andrea TA, Diller DJ (2002) Use of catalyst pharmacophore models for screening of large combinatorial libraries. J Chem Inf Comput Sci 42:1204-1211 (Pubitemid 35360306)
9. Israili ZH, Hall WD (1992) Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med 117:234-242
10. Kurogi Y, Guner OF (2001) Pharmacophore modeling and three dimensional database searching for drug design using catalyst. Curr Med Chem 8:1035-1055 (Pubitemid 32633658)
11. Langer T, Krovat EM (2003) Chemical feature based pharmacophores and virtual library screening for discovery of new-leads. Curr Opin Drug Discov Dev 6:370-376 (Pubitemid 36702310)
12. Mason JS, Good AC, Martin EJ (2001) 3-D pharmacophores in drug discovery. Curr Pharm Des 7:567-597 (Pubitemid 32427655)
13. Ondetti MA, Cushman DW (1981) Inhibition of the renin angiotensin system: a new approach to the therapy of hypertension. J Med Chem 24:355-361 (Pubitemid 11151637)
14. Paliwal SK, Pal M, Siddiqui AA (2010) Quantitative structure activity relationship analysis of angiotensinII AT1 receptor antagonist. Med Chem Res 19:475-489
15. Paliwal S, Yadav D, Yadav R, Paliwal S (2011a) In silico structure based drug design approach to develop novel pharmacophore model of human peroxisome proliferator activated receptor (PPARc) agonists. Med Chem Res 20:656-659. doi:10.1007/s00044-010-9370-x
16. Paliwal S, Seth D, Yadav D, Paliwal S, Yadav R (2011b) Development of a robust QSAR model to predict the affinity of pyrrolidine analogs for dipeptidyl peptidase IV (DPP-IV). J Enzym Inhib Med Chem 26:129-140. doi:10.3109/ 14756361003777057
17. Smellie A, Teig S, Towbin P (1995) Poling: promoting conformational variation. J Comput Chem 16:171-187
18. Sprague PW (1995) Automated chemical hypothesis generation and database searching with catalyst. Perspect Drug Discov Des 3:1-20
19. Sutter J, Guner O, Hoddmann R, Li H, Waldman M (2000) In: Guner OF (ed) Pharmacophore, perception, development and use in drug design. International University Line, La Jolla, CA, pp 504-506
20. Tuccinardi T, Calderone V, Rapposelli S, Martinelli A (2006) Proposal of a new binding orientation for non-peptide AT1 antagonists. J Med Chem 49:4305-4316
21. Wong J, Patel RA, Kowey PR (2004) The clinical use of angiotensin converting enzyme inhibitors. Prog Cardiovasc Dis 47:116-130 (Pubitemid 39600946)